Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 31, 115969
Abstract
No abstract availableKeywords
Funding Information
- Korea Institute of Science and Technology
This publication has 46 references indexed in Scilit:
- Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methyl-N-propylpyrrolo[1,2-f][1,2,4]triazine-6-carboxamide (BMS-582949), a Clinical p38α MAP Kinase Inhibitor for the Treatment of Inflammatory DiseasesJournal of Medicinal Chemistry, 2010
- RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma ModelsCancer Research, 2010
- Signal integration by JNK and p38 MAPK pathways in cancer developmentNature Reviews Cancer, 2009
- SD0006: A Potent, Selective and Orally Available Inhibitor of p38 KinasePharmacology, 2009
- A potent and selective p38 inhibitor protects against bone damage in murine collagen‐induced arthritis: a comparison with neutralization of mouse TNFαBritish Journal of Pharmacology, 2008
- A Sensitive Direct ELISA for Detection of Prostaglandin E 2Journal of Immunoassay and Immunochemistry, 2007
- Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathwaysFEBS Letters, 2005
- The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor β-induced Smad signaling in human ovarian cancer cellsBiochemical and Biophysical Research Communications, 2003
- Improved detection of nitric oxide radical (NO•) production in an activated macrophage culture with a radical scavenger, car☐y PTIO, and Griess reagentFEBS Letters, 1995
- A general method applicable to the search for similarities in the amino acid sequence of two proteinsJournal of Molecular Biology, 1970